|
| Author, year | Antibiotics used | Length of antibiotic course | Anticoagulation/Antiplatelet given | Length of anticoagulation course | Source |
|
1 | Laurencet, Marie-Eva et al., 2020 | Amoxicillin-clavulanate + clindamycin | 6 weeks | Acenocoumarol | 12 weeks | [21] |
2 | Goan, Hannah et al., 2021 | Meropenem + vancomycin | N/A | Apixaban + clopidogrel | N/A | [22] |
3 | Lee, Seung Eun et al., 2021 | Amoxicillin-clavulanate + clindamycin | 6 weeks | Rivaroxaban | 12 weeks | [23] |
4 | Latif, Azka et al., 2021 | Vancomycin + pipera cillin/tazobactam ⟶ vancomycin + doxycycline + meropenem | 12 weeks | Apixaban | Not specified | [24] |
5 | Lanfear, Allison et al., 2020 | Ceftriaxone and metronidazole | 6 weeks | N/A | N/A | [25] |
6 | Zhao, Andrew, et al., 2017 | Piperacillin/tazobactam + IV vancomycin ⟶ ceftriaxone + metronidazole | N/A | N/A | N/A | [26] |
7 | Santos, Fabio Videira et al., 2020 | Ceftriaxone and metronidazole | 2 weeks | Enoxaparin | 12 weeks | [27] |
8 | Jaber, Tariq et al., 2021 | Ampicillin-sulbactam + 1 dose of gentamicin ⟶ amoxicillin-clavulanic | 6 weeks | N/A | N/A | [4] |
9 | Jaber, Tariq et al., 2021 | Ceftriaxone + azithromycin ⟶ piperacillin-tazobactam and levofloxacin ⟶ piperacillin-tazobactam and clindamycin ⟶ amoxicillin-clavulanate | N/A | Heparin ⟶ warfarin | 14 weeks | [4] |
10 | Jaber, Tariq et al., 2021 | Cefepime and metronidazole ⟶ ampicillin-sulbactam ⟶ amoxicillin-clavulanate | 6 weeks | Apixaban | 12 weeks | [4] |
11 | Jaber, Tariq et al, 2021 | Meropenem and vancomycin ⟶ ampicillin-sulbactam | 6 weeks | N/A | N/A | [4] |
12 | Costa, Fatima et al., 2021 | Ceftriaxone, azithromycin ⟶ ? maybe kept at same medication | 3 weeks | Heparin ⟶ rivaroxaban | 16 weeks | [28] |
13 | Karn, Michele et al., 2020 | Clindamycin, vancomycin, ceftriaxone, and ampicillin/sulbactam ⟶ meropenem | 5 weeks | Enoxaparin | 5 weeks | [29] |
14 | Alves, Sergio et al., 2019 | Amoxicillin/clavulanate + metronidazole | 6 weeks | Enoxaparin | 14 weeks | [30] |
15 | Ngu, Vincent et al., 2018 | Amoxicillin/clavulanate ⟶ amoxicillin/clavulanate + metronidazole | 2 weeks | Not specified | 2 weeks | [31] |
16 | Dasari, Suhas et al., 2020 | IV ceftriaxone and oral metronidazole | 4 weeks | Warfarin | 12 weeks | [32] |
17 | Mellor, Thomas et al., 2017 | Piperacillin/tazobactam ⟶ ertapenem | 4 weeks | N/A | N/A | [33] |
18 | Gohal, Satan et al. 2021 | Piperacillin-tazobactam and clindamycin | 6 weeks | Enoxaparin | Not specified | [34] |
19 | Jawad et al., 2018 | Amoxicillin/clavulanate + clarithromycin ⟶ piperacillin-tazobactam + metronidazole ⟶ amoxicillin/clavulanate | 6 weeks | Low molecular weight heparin ⟶ rivaroxaban | 12 weeks | [35] |
20 | Gonzalez et al., 2019 | Vancomycin and piperacillin/tazobactam ⟶ vancomycin | 4 weeks | IV heparin ⟶ oral apixaban | 10 days | [36] |
21 | Garcia et al., 2017 | i.v, cefepime, and metronidazole ⟶ IV metronidazole ⟶ amoxicillin‐clavulanate | 6 weeks | IV heparin ⟶ warfarin | Not specified | [37] |
22 | Barguil et al., 2021 | Ceftriaxone, metronidazole, and linezolid ⟶ amoxicillin-clavulanic acid | 4 weeks | Enoxaparin | 4 weeks | [38] |
23 | Sattar et al., 2020 | Meropenem ⟶ piperacillin/tazobactam ⟶ clindamycin | 3 weeks | Heparin ⟶ warfarin | Not specified | [39] |
24 | Howley et al., 2020 | Ceftriaxone, vancomycin, and metronidazole ⟶ intravenous ceftriaxone and oral metronidazole | 12 weeks | Enoxaparin | 12 weeks | [40] |
25 | Man, Man-Yee et al., 2018 | Doxycycline, clindamycin, and vancomycin ⟶ meropenem + doxycycline ⟶ amoxicillin-clavulanate | 6 weeks | N/A | N/A | [41] |
26 | De Oliveira, Rodrigo et al., 2018 | Azithromycin, clindamycin, and ceftriaxone ⟶ clindamycin, and ceftriaxone | 10 days | N/A | N/A | [12] |
|